Quantcast

Latest Brain tumor Stories

2014-08-11 08:29:18

Trial Progressing On Track; BETHESDA, Md., Aug. 11, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced an update about the Company's Phase III clinical trial of DCVax®-L for Glioblastoma multiforme (GBM) brain cancer in conjunction with the Company's separate announcement today about certain changes to the Phase III trial. The update from the Company...

2014-08-08 11:20:47

Cell Transplantation Center of Excellence for Aging and Brain Repair Induced immunorejection may eliminate tumors post-cell transplantation Recent studies have shown that transplanting induced pluripotent stem cell-derived neural stem cells (iPS-NSCs) can promote functional recovery after spinal cord injury in rodents and non-human primates. However, a serious drawback to the transplantation of iPS-NSCs is the potential for tumor growth, or tumorogenesis, post-transplantation. In an...

2014-08-07 23:09:09

NuvOx Pharma, a Tucson based biotechnology company, began a Phase Ib clinical trial of its new drug NVX-108 in patients with glioblastoma, a deadly form of brain cancer. Tucson, AZ (PRWEB) August 07, 2014 NuvOx Pharma, a privately held biotechnology company based in Tucson, Arizona, focused on developing a nanotechnology platform for reversing conditions with decreased oxygen announced that on July 14th, it began a Phase Ib clinical trial of its new drug NVX-108 in patients with...

2014-08-05 08:33:58

POINT ROBERTS, Wash. and NEW YORK, Aug. 5, 2014 /PRNewswire/ -- Investorideas.com, a global news source covering leading sectors including biotech, issues an exclusive Q&A interview with Dr. Craig Dionne, PhD, GenSpera's (OTCQB: GNSZ) CEO. Dr. Dionne discusses the company's lead drug G-202 and how they have taken a powerful toxin named thapsigargin to selectively target and kill cancer cells. He also shares insight into the key points that make them different from competitive...

2014-08-04 09:29:32

Washington University School of Medicine New research at Washington University School of Medicine in St. Louis helps explain why brain tumors occur more often in males and frequently are more harmful than similar tumors in females. For example, glioblastomas, the most common malignant brain tumors, are diagnosed twice as often in males, who suffer greater cognitive impairments than females and do not survive as long. The researchers found that retinoblastoma protein (RB), a protein...

2014-08-04 08:27:33

- Results from Phase I program in glioblastoma multiforme presented at ASCO earlier this year NORTH CHICAGO, Ill., Aug. 4, 2014 /PRNewswire/ -- AbbVie (NYSE:ABBV) today announced the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) have granted orphan drug designation to AbbVie's investigational compound ABT-414, an anti-epidermal growth factor receptor antibody drug conjugate, which is being evaluated for safety and efficacy in patients with...

2014-07-31 23:05:46

The ANS Skull Base Surgery Center offers hope for patients who suffer from brain tumors, acoustic neuromas, pituitary tumors, skull base meningiomas, trigeminal neuralgia, spinal fluid leaks, and aneurysms. Morristown, NJ (PRWEB) July 31, 2014 ANS and Dr. Yaron Moshel offer answers to some common questions they receive about the ANS Skull Base Center and what the future holds for Brain Tumor Surgery. What is the ANS Skull Base Surgery Center? Skull base surgery is a form of highly...

2014-07-30 23:14:01

With the rising popularity of “boutique surgeries” being offered by less qualified specialists, ANS has launched an awareness campaign to educate the community on the importance of choosing a neurosurgeon for an accurate diagnosis and to dismiss the idea that you only go to a neurosurgeon when surgery is needed. Morristown, NJ (PRWEB) July 30, 2014 Stroke Treatment Atlantic NeuroSurgical Specialists continues to be a leader in the war against stroke. In 2012, ANS became the first...

2014-07-30 08:33:10

Article in "Neurosurgery" describes how RapidArc Radiosurgery treatments can be specially optimized to treat multiple brain metastases at the same time PALO ALTO, Calif., July 30, 2014 /PRNewswire/ -- RapidArc(®) Radiosurgery can be used to deliver treatments for multiple brain metastases that are substantially less time consuming and comparable in quality to Gamma Knife(® )(GK) treatments, according to a new research study recently posted online and slated for publication in the...

2014-07-28 23:05:11

National Brain Tumor Society connects biotech company to researchers’ technology. Hershey, PA & Boston, MA (PRWEB) July 28, 2014 Immunomic Therapeutics, Inc. (ITI) has entered into collaboration agreements with two researchers to further develop potential treatments for glioblastoma multiforme (GBM), the most common and deadly malignant brain tumor, in combination with their patented vaccine platform, LAMP-vax. The agreements, recently executed by ITI and Duke University, are based...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related